1. Home
  2. BDTX vs CRNX Comparison

BDTX vs CRNX Comparison

Compare BDTX & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • CRNX
  • Stock Information
  • Founded
  • BDTX 2014
  • CRNX 2008
  • Country
  • BDTX United States
  • CRNX United States
  • Employees
  • BDTX N/A
  • CRNX N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • CRNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BDTX Health Care
  • CRNX Health Care
  • Exchange
  • BDTX Nasdaq
  • CRNX Nasdaq
  • Market Cap
  • BDTX 132.5M
  • CRNX 2.8B
  • IPO Year
  • BDTX 2020
  • CRNX 2018
  • Fundamental
  • Price
  • BDTX $2.58
  • CRNX $30.00
  • Analyst Decision
  • BDTX Strong Buy
  • CRNX Strong Buy
  • Analyst Count
  • BDTX 6
  • CRNX 10
  • Target Price
  • BDTX $14.83
  • CRNX $75.00
  • AVG Volume (30 Days)
  • BDTX 1.3M
  • CRNX 646.9K
  • Earning Date
  • BDTX 08-05-2025
  • CRNX 08-07-2025
  • Dividend Yield
  • BDTX N/A
  • CRNX N/A
  • EPS Growth
  • BDTX N/A
  • CRNX N/A
  • EPS
  • BDTX 0.09
  • CRNX N/A
  • Revenue
  • BDTX $70,000,000.00
  • CRNX $760,000.00
  • Revenue This Year
  • BDTX N/A
  • CRNX $402.12
  • Revenue Next Year
  • BDTX N/A
  • CRNX $770.88
  • P/E Ratio
  • BDTX $29.29
  • CRNX N/A
  • Revenue Growth
  • BDTX N/A
  • CRNX N/A
  • 52 Week Low
  • BDTX $1.20
  • CRNX $24.10
  • 52 Week High
  • BDTX $6.75
  • CRNX $62.53
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 60.65
  • CRNX 44.17
  • Support Level
  • BDTX $2.43
  • CRNX $28.34
  • Resistance Level
  • BDTX $2.72
  • CRNX $30.01
  • Average True Range (ATR)
  • BDTX 0.18
  • CRNX 1.07
  • MACD
  • BDTX -0.00
  • CRNX -0.17
  • Stochastic Oscillator
  • BDTX 76.11
  • CRNX 36.41

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Share on Social Networks: